MedChemExpress

LY294002

#HY-10358

32
Citing papers
581
Combined citations
Supplier page Find this product

Research areas

PI3K/AKT/mTOR signaling in cancer4Melanoma and MAPK Pathways314-3-3 protein interactions3Cytokine Signaling Pathways and Interactions3Ubiquitin and proteasome pathways3Hippo pathway signaling and YAP/TAZ2GDF15 and Related Biomarkers2Cancer-related molecular mechanisms research2

Papers citing this product

1
Andrographolide Protects against HG-Induced Inflammation, Apoptosis, Migration, and Impairment of Angiogenesis via PI3K/AKT-eNOS Signalling in HUVECs
Mediators of Inflammation·2019·108 cit.·DOI
2
Human umbilical cord-derived mesenchymal stem cell transplantation supplemented with curcumin improves the outcomes of ischemic stroke via AKT/GSK-3β/β-TrCP/Nrf2 axis
Journal of Neuroinflammation·2023·71 cit.·DOI
3
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma
Cancer Communications·2023·48 cit.·DOI
4
Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling
Aging·2020·45 cit.·DOI
5
Adaptor protein HIP-55-mediated signalosome protects against ferroptosis in myocardial infarction
Cell Death and Differentiation·2023·43 cit.·DOI
6
The Role of TRPC6 in Renal Ischemia/Reperfusion and Cellular Hypoxia/Reoxygenation Injuries
Frontiers in Molecular Biosciences·2021·36 cit.·DOI
7
Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers
Cancers·2020·30 cit.·DOI
8
Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
Cancer Research·2024·29 cit.·DOI
9
MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition
Endocrine Related Cancer·2019·26 cit.·DOI
10
Pro‐inflammatory cytokine IL‐6 regulates LMO4 expression in psoriatic keratinocytes via AKT/STAT3 pathway
Immunity Inflammation and Disease·2023·20 cit.·DOI

Similar products

ProductVendorPricePapers
LY294002MedChemExpress—84
GDC-0941MedChemExpress—36
WortmanninMedChemExpress—20
PictilisibMedChemExpress—8
LY294002 — Evidence — PubIndex